"I don't know about these things, can't you explain them to me properly?" Luo Ziling roared at Ouyang Feifei in annoyance and embarrassment.
"I just want to tell you that the money you invested could appreciate quickly," Ouyang Feifei ignored Luo Ziling's annoyed embarrassment, "Last year, Lingyun Group's earnings per share were 2.75 yuan, and the year before that, it was 0.85 yuan. The market price-earnings ratios in the pharmaceutical industry aren't high. Lingyun Group's share price is around 20 yuan, and if we calculate it based on the previous year's earnings per share, the price-earnings ratio is around 23 times, which is normal for the industry. Now it has risen to 40 yuan, but if we calculate it with an earnings per share of 2.75 yuan, the price-earnings ratio is actually quite low. If we take 20 times the price-earnings ratio, the corresponding share price should be over 50 yuan."
